Soluble human insulin — DKA infusion
Pregnancy & gynaecology-specific. Every dose row is source-referenced; verify against institutional protocols.
Soluble human insulin — DKA infusionEMERGENCY KITEndocrine Metabolic
Regimens checked: 2026-10-17. Each indication has its own preparation, limits and safety checks.
| Indication | Dose | Route | Frequency | Duration / preparation | Maximum | Monitoring / cautions |
|---|---|---|---|---|---|---|
Pregnancy DKA, including euglycaemic DKA; urgent monitored obstetric/diabetes care | 0.1 units/kg/hour IV; no routine IV insulin bolus. Consider 0.05 units/kg/hour once glucose <14 mmol/L alongside glucose infusion | IV infusion pump | Continuous with hourly response-based review | Continue until ketones <0.6 mmol/L AND venous pH >7.3, clinical recovery and safe transition; not merely until glucose normalises · Using U-100 SOLUBLE insulin: 50 units =0.5 mL; add to 49.5 mL sodium chloride 0.9% for FINAL 50 mL =1 unit/mL. At 0.1 units/kg/h, 70 kg =7 units/h =7 mL/h. NEVER use cloudy NPH IV | No universal fixed hourly ceiling; inadequate ketone fall needs line/pump and dose reassessment. Potassium <3.5 mmol/L requires urgent senior-led replacement and insulin review | Monitor
|
Pregnancy safety
Pregnancy DKA requires a joint obstetric/diabetes/critical-care plan.
Lactation
Acute maternal stabilisation takes priority; review ongoing treatment and infant exposure with the linked source and specialist team.
JBDS-IP / Diabetes UKcheckedIN REVIEW